Acura Pharmaceuticals Executives

ACURDelisted Stock  USD 0.05  0.00  0.00%   
Acura Pharmaceuticals employs about 12 people. The company is managed by 11 executives with a total tenure of roughly 182 years, averaging almost 16.0 years of service per executive, having 1.09 employees per reported executive. Discussion of Acura Pharmaceuticals' management performance can provide insight into the enterprise performance.
Robert Jones  CEO
CEO and President and Director
James Emigh  President
Vice President - Corporate Development
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

Acura Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.3842) % which means that it has lost $0.3842 on every $100 spent on assets. This is way below average. Acura Pharmaceuticals' management efficiency ratios could be used to measure how well Acura Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Acura Pharmaceuticals Workforce Comparison

Acura Pharmaceuticals is rated third in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 198. Acura Pharmaceuticals holds roughly 12.0 in number of employees claiming about 6% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.51) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.49.

Acura Pharmaceuticals Notable Stakeholders

An Acura Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Acura Pharmaceuticals often face trade-offs trying to please all of them. Acura Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Acura Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert JonesCEO and President and DirectorProfile
James EmighVice President - Corporate DevelopmentProfile
Peter ClemensCFO, Principal Accounting Officer, Sr. VP and SecretaryProfile
George RossIndependent DirectorProfile
Bruce WessonIndependent DirectorProfile
Immanuel ThangarajIndependent DirectorProfile
William SkellyIndependent DirectorProfile
Albert BrzeczkoVP of Technical AffairsProfile
Robert SeiserVP, Treasurer and Corporate ControllerProfile
Bradley RivetVP of MarketingProfile
Mr CPATreasurer VPProfile

About Acura Pharmaceuticals Management Performance

The success or failure of an entity such as Acura Pharmaceuticals often depends on how effective the management is. Acura Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Acura management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Acura management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
The data published in Acura Pharmaceuticals' official financial statements usually reflect Acura Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acura Pharmaceuticals. For example, before you start analyzing numbers published by Acura accountants, it's critical to develop an understanding of what Acura Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Acura Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acura Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acura Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acura Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Acura Pharmaceuticals' management manipulating its earnings.

Acura Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Acura Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Acura Pharmaceuticals within its industry.

Acura Pharmaceuticals Manpower Efficiency

Return on Acura Pharmaceuticals Manpower

Revenue Per Employee297.5K
Revenue Per Executive324.5K
Net Loss Per Employee100.7K
Net Loss Per Executive109.8K
Working Capital Per Employee907.6K
Working Capital Per Executive990.1K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Acura OTC Stock

If you are still planning to invest in Acura Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acura Pharmaceuticals' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories